Results 131 to 140 of about 13,123 (252)

Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer [PDF]

open access: hybrid, 2023
Rosemary Noel Senguttuvan   +22 more
openalex   +1 more source

Don’t Call It a Comeback—HIPEC for Gastric Cancer

open access: yesAnnals of Surgical Oncology, 2022
B. Badgwell
semanticscholar   +1 more source

HIPEC

open access: yes
Ovarian cancer is the third most common and deadliest gynecologic cancer. The lack of specific symptoms often leads to delayed diagnosis and advanced disease with extensive peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a technique in which heated chemotherapy is delivered into the abdominal cavity after cytoreductive ...
openaire   +2 more sources

HIPEC στον καρκίνο του στομάχου

open access: yes, 2021
Gastric cancer constitutes the third most common malignancy worldwide and the third most common cause of death due to malignancy. The incidence of the disease differs depending on the area, the race and the gender. The prognosis as well as the treatment options depend largely on the stage of the disease.
openaire   +1 more source

Health Related Quality of Life after Interval Cytoreductive Surgery with or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Stage III Ovarian Cancer

open access: green, 2018
Simone N. Koole   +15 more
openalex   +1 more source

Treatment planning software for HIPEC

open access: yes, 2023
Peritoneal metastases (PM) predominantly originate from primary cancers such as colorectal, ovarian and gastric cancer. Survival rates decrease dramatically when metastases develop in the peritoneal cavity. The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) offers a treatment option that can ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy